» Articles » PMID: 22248085

Opportunities for Sensitive Plasma Proteome Analysis

Overview
Journal Anal Chem
Specialty Chemistry
Date 2012 Jan 18
PMID 22248085
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Despite great interest, investments, and efforts, the ongoing search for plasma protein biomarkers for disease so far has come up surprisingly empty-handed. Although discovery programs have revealed large numbers of biomarker candidates, the clinical utility has been validated for only a very small number of these. While this disappointing state of affairs may suggest that plasma protein biomarkers have little more to offer for diagnostics, we take the perspective that experimental conditions might not have been optimal and that analyses will be required that offer far greater sensitivity than currently available, in terms of numbers of molecules needed for unambiguous detection. Accordingly, techniques are needed to search deep and wide for protein biomarker candidates. The requirements and feasibility of such assays will be discussed.

Citing Articles

Fine tuning of neurointensive care in aneurysmal subarachnoid hemorrhage: From one-size-fits-all towards individualized care.

Svedung Wettervik T, Lewen A, Enblad P World Neurosurg X. 2023; 18:100160.

PMID: 36818739 PMC: 9932216. DOI: 10.1016/j.wnsx.2023.100160.


A Dedicated 21-Plex Proximity Extension Assay Panel for High-Sensitivity Protein Biomarker Detection Using Microdialysis in Severe Traumatic Brain Injury: The Next Step in Precision Medicine?.

Dyhrfort P, Svedung Wettervik T, Clausen F, Enblad P, Hillered L, Lewen A Neurotrauma Rep. 2023; 4(1):25-40.

PMID: 36726870 PMC: 9886191. DOI: 10.1089/neur.2022.0067.


Resolving Molecular Heterogeneity with Single-Molecule Centrifugation.

Luo Y, Chang J, Yang D, Bryan 4th J, MacIsaac M, Presse S J Am Chem Soc. 2023; 145(6):3276-3282.

PMID: 36716175 PMC: 9936575. DOI: 10.1021/jacs.2c11450.


Contribution of Multiplex Immunoassays to Rheumatoid Arthritis Management: From Biomarker Discovery to Personalized Medicine.

Laborde C, Castro-Santos P, Diaz-Pena R J Pers Med. 2020; 10(4).

PMID: 33142977 PMC: 7712300. DOI: 10.3390/jpm10040202.


Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations.

Landegren U, Hammond M Mol Oncol. 2020; 15(6):1715-1726.

PMID: 33012111 PMC: 8169444. DOI: 10.1002/1878-0261.12809.